Milica Pesic
Milica Pesic
Institute for Biological Research "Sinisa Stankovic" - National Institute of Republic of Serbia
Potvrđena adresa e-pošte na
Anti-cancer effects of cerium oxide nanoparticles and its intracellular redox activity
M Pešić, A Podolski-Renić, S Stojković, B Matović, D Zmejkoski, V Kojić, ...
Chemico-biological interactions 232, 85-93, 2015
Induced resistance in the human non small cell lung carcinoma (NCI-H460) cell line in vitro by anticancer drugs
M Pesic, JZ Markovic, D Jankovic, S Kanazir, ID Markovic, L Rakic, ...
Journal of chemotherapy 18 (1), 66-73, 2006
Elucidation and in planta reconstitution of the parthenolide biosynthetic pathway
Q Liu, D Manzano, N Tanić, M Pesic, J Bankovic, I Pateraki, L Ricard, ...
Metabolic engineering 23, 145-153, 2014
Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line (NCI-H460/R)
T Andjelkovic, M Pesic, J Bankovic, N Tanic, ID Markovic, S Ruzdijic
Cancer biology & therapy 7 (7), 1024-1032, 2008
Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
V Lopes-Rodrigues, A Di Luca, J Mleczko, P Meleady, M Henry, M Pesic, ...
Scientific Reports 7, 44541, 2017
The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines
A Podolski-Renić, T Anđelković, J Banković, N Tanić, S Ruždijić, M Pešić
Biomedicine & Pharmacotherapy 65 (5), 345-353, 2011
Isolation and biological evaluation of jatrophane diterpenoids from Euphorbia dendroides
IS Aljančić, M Pešić, SM Milosavljević, NM Todorović, M Jadranin, ...
Journal of natural products 74 (7), 1613-1620, 2011
Targeting RAS-MAPK-ERK and PI3K-AKT-mTOR signal transduction pathways to chemosensitize anaplastic thyroid carcinoma
Z Milosevic, M Pesic, T Stankovic, J Dinic, Z Milovanovic, J Stojsic, ...
Translational Research 164 (5), 411-423, 2014
What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg
T Alexa-Stratulat, M Pešić, AČ Gašparović, IP Trougakos, C Riganti
Drug Resistance Updates 46, 100643, 2019
Advanced technological tools to study multidrug resistance in cancer
L Andrei, S Kasas, IO Garrido, T Stanković, MS Korsnes, R Vaclavikova, ...
Drug Resistance Updates 48, 100658, 2020
Jatrophane diterpenoids from the latex of Euphorbia dendroides and their anti-P-glycoprotein activity in human multi-drug resistant cancer cell lines
M Jadranin, M Pešić, IS Aljančić, SM Milosavljević, NM Todorović, ...
Phytochemistry 86, 208-217, 2013
Cytotoxic activity of sesquiterpene lactones from Inula britannica on human cancer cell lines
JT Fischedick, M Pesic, A Podolski-Renic, J Bankovic, RCH de Vos, ...
Phytochemistry Letters 6 (2), 246-252, 2013
Dual inhibitors as a new challenge for cancer multidrug resistance treatment
T Stanković, J Dinić, A Podolski-Renić, L Musso, SS Burić, S Dallavalle, ...
Current medicinal chemistry 26 (33), 6074-6106, 2019
New anti-cancer characteristics of jatrophane diterpenes from< i> Euphorbia dendroides</i>
M Pešić, J Banković, IS Aljančić, NM Todorović, M Jadranin, VE Vajs, ...
Food and Chemical Toxicology, 2011
New Approaches With Natural Product Drugs for Overcoming Multidrug Resistance in Cancer
J Dinic, A Podolski-Renic, T Stankovic, J Bankovic, M Pesic
Current Pharmaceutical Design 21 (38), 5589-5604, 2015
Ferrocene–cinchona hybrids with triazolyl-chalcone linkers act as pro-oxidants and sensitize human cancer cell lines to paclitaxel
A Podolski-Renić, S Bősze, J Dinić, L Kocsis, F Hudecz, A Csámpai, ...
Metallomics 9 (8), 1132-1141, 2017
A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo [3, 4-d] Pyrimidine Dual Src/P-Glycoprotein Inhibitor
AL Fallacara, C Zamperini, A Podolski-Renić, J Dinić, T Stanković, ...
Cancers 11 (6), 848, 2019
Applied mathematics and nonlinear sciences in the war on cancer
VM Pérez-García, S Fitzpatrick, LA Pérez-Romasanta, M Pesic, P Schucht, ...
Applied Mathematics and Nonlinear Sciences 1 (2), 423-436, 2016
Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma
M Dragoj, Z Milosevic, J Bankovic, N Tanic, M Pesic, T Stankovic
Cellular Oncology 40 (1), 47-62, 2017
Understanding Cancer Drug Resistance by Developing and Studying Resistant Cell Line Models
C PR Xavier, M Pesic, M Helena Vasconcelos
Current cancer drug targets 16 (3), 226-237, 2016
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20